| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 809 |
| 1 | ADALIMUMAB | 751 |
| 2 | PREDNISONE | 733 |
| 3 | METHOTREXATE | 731 |
| 4 | RITUXIMAB | 694 |
| 5 | TOCILIZUMAB | 680 |
| 6 | INFLIXIMAB | 664 |
| 7 | ETANERCEPT | 662 |
| 8 | ABATACEPT | 651 |
| 9 | SULFASALAZINE | 632 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 164 | 0.0282 |
| 1 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 14 | 0.0226 |
| 2 | CHLOROQUINE PHOSPHATE | 10 | 0.0152 |
| 3 | PRAMIPEXOLE DIHYDROCHLORIDE | 70 | 0.0144 |
| 4 | FEBUXOSTAT TABLETS 40 MG | 144 | 0.0138 |
| 5 | DIMENHYDRINATE | 147 | 0.0137 |
| 6 | INTERLEUKIN-10 | 4 | 0.0111 |
| 7 | MOTIXAFORTIDE | 1 | 0.0098 |
| 8 | FEBUXOSTAT | 165 | 0.0097 |
| 9 | CODEINE PHOSPHATE AND GUAIFENESIN | 1 | 0.0093 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 898 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 812 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 748 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 705 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 685 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 651 |
| 6 | Aminosalicylate [EPC] | 645 |
| 7 | Antirheumatic Agent [EPC] | 615 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 435 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 309 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 188 | 0.0071 |
| 1 | Aminosalicylate [EPC] | 645 | 0.0064 |
| 2 | Antirheumatic Agent [EPC] | 615 | 0.0058 |
| 3 | Provitamin D2 Compound [EPC] | 156 | 0.0052 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 685 | 0.0049 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 651 | 0.0047 |
| 6 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 7 | Interleukin-17A Antagonist [EPC] | 157 | 0.0042 |
| 8 | Parenteral Iron Replacement [EPC] | 41 | 0.0030 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 5 | 0.0024 |